Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Vaccine ; 23(17-18): 2284-9, 2005 Mar 18.
Artigo em Inglês | MEDLINE | ID: mdl-15755612

RESUMO

We have the knowledge and tools to eliminate the threat of canine rabies but this disease, nevertheless, remains a public health threat in many parts of the world. Lack of motivation by governments, cultural issues and inadequate funding remain barriers. This is amazing since the number of human rabies deaths worldwide is greater than that from polio, meningococcal meningitis, Japanese encephalitis, yellow fever, SARS, bird flue and other scourges that attract more attention. Safe and effective vaccines are now widely available. Reduced dose effective and less expensive post-exposure vaccination regimens have helped eliminate nerve tissue vaccines in Thailand, Philippines and Sri Lanka. India and Pakistan, the major users of dangerous nerve tissue derived Semple type vaccine, are now considering following suite. Immediate wound care and prompt use of a potent vaccine will save a majority of infected persons. Rabies immunoglobulin, injected into and around bite wounds, provides added safety for the severely exposed. The high cost of rabies immunoglobulin and tissue culture vaccines are remaining barriers, but new manufacturers and the use of intradermal vaccination schedules can reduce costs. Ultimately, it is the need to control rabies in dogs that must occupy most of our attention. The tools are available, but attitudes must change before they can be applied. There have been many new developments since publication of the last WHO rabies expert committee report in 1992 (new version in print)] and we will address those that have practical applicability.


Assuntos
Raiva/prevenção & controle , Animais , Anticorpos Antivirais/sangue , Ásia , Sudeste Asiático , Doenças do Cão/imunologia , Doenças do Cão/prevenção & controle , Cães , Raiva/diagnóstico , Raiva/terapia , Raiva/veterinária , Vacina Antirrábica/administração & dosagem , Vírus da Raiva/imunologia
2.
Vaccine ; 21(25-26): 3525-6, 2003 Sep 08.
Artigo em Inglês | MEDLINE | ID: mdl-12922076

RESUMO

We report the case of a 7-year-old Thai girl that was bitten by a dog. She received prompt wound care followed by eight-site intradermal post-exposure rabies schedule using purified chick embryo vaccine. Treatment followed WHO recommendations for desperate situations where no rabies immune globulin (RIG) is available. The patient died 15 days later with classical symptoms and signs of encephalitic rabies.


Assuntos
Doenças do Cão/virologia , Vacina Antirrábica/uso terapêutico , Raiva/prevenção & controle , Raiva/veterinária , Animais , Embrião de Galinha , Criança , Cães , Feminino , Humanos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA